Terms: = Skin cancer AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984 AND Treatment
3 results:
1. Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma.
Thompson JC; Davis C; Deshpande C; Hwang WT; Jeffries S; Huang A; Mitchell TC; Langer CJ; Albelda SM
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028693
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach.
Metri R; Mohan A; Nsengimana J; Pozniak J; Molina-Paris C; Newton-Bishop J; Bishop D; Chandra N
Sci Rep; 2017 Dec; 7(1):17314. PubMed ID: 29229936
[TBL] [Abstract] [Full Text] [Related]
3. Potential diagnostic significance of HSP90, ACS/TMS1, and L-plastin in the identification of melanoma.
Strickler AG; Vasquez JG; Yates N; Ho J
Melanoma Res; 2014 Dec; 24(6):535-44. PubMed ID: 25191796
[TBL] [Abstract] [Full Text] [Related]
